Phase 1 Kidney Diseases Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Heart FailureChronic Kidney DiseasesKidney Diseases+1 more
Northwestern University60 enrolled1 locationNCT05719714
Recruiting
Phase 1
Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
Chronic Kidney DiseasesRenal Transplantation
Qianfoshan Hospital30 enrolled1 locationNCT07045467
Recruiting
Phase 1
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD
Chronic Kidney Diseases
The Foundation for Orthopaedics and Regenerative Medicine20 enrolled1 locationNCT05018845
Recruiting
Phase 1
Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)
Chronic Kidney DiseasesRenal Failure
Hamilton Health Sciences Corporation200 enrolled3 locationsNCT06203977
Recruiting
Phase 1
Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease
Chronic Kidney Diseases
EHL Bio Co., Ltd.6 enrolled1 locationNCT06071143